Western blot (WB) analysis of JIP3 (Q649) pAb in extracts from HeLa cells. Immunohistochemistry (IHC) analyzes of JIP3 (Q649) pAb in paraffin-embedded human lung carcinoma tissue.
Theoretical MW
147 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Publications
Read Publications using NBP1-00895 in the following applications:
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
PBS (pH 7.2)
Preservative
0.05% Sodium Azide
Concentration
1.0 mg/ml
Purity
Immunogen affinity purified
Alternate Names for JNK/JIP3 Antibody
C-jun-amino-terminal kinase interacting protein 3
C-Jun-amino-terminal kinase-interacting protein 3
DKFZp762N1113
homolog of Drosophila Sunday driver 2
JIP-3
JIP3FLJ00027
JNK MAP kinase scaffold protein 3
JNK/SAPK-associated protein-1
JNK/stress-activated protein kinase-associated protein 1
JNK-interacting protein 3
JSAP1
KIAA1066SYD2
mitogen-activated protein kinase 8 interacting protein 3
Mitogen-activated protein kinase 8-interacting protein 3
syd
Background
c-Jun NH2-terminal kinases (JNKs) are distant members of the MAP kinase family. JNK1 is activated by dual phosphorylation at a Thr-Pro-Tyr motif in response to ultraviolet (UV) light, and it functions to phosphorylate c-Jun at amino terminal serine regulatory sites Ser 63 and Ser 73, resulting in transcriptional activation. Two additional JNK family members, JNK2 and JNK3, have been identified. JIP-1 (for JNK interacting protein-1) has been identified as a cytoplasmic inhibitor of JNK that retains JNK in the cytoplasm, thereby inhibiting JNK-regulated gene expression. Evidence suggests that JNK1 and JNK2 bind to JIP-1 with greater affinity than to ATF-2 and c-Jun, which are targets of the JNK signaling pathway. JIP-1 contains an amino terminal JNK binding domain and a carboxy terminal SH3 domain. ATF-2 and c-Jun also contain the JNK binding domain and are thought to compete with JIP-1 for JNK binding. Multiple splice variants of JIP-1, including JIP-1b, JIP-1c (also designated islet-brain 1 or IB-1), JIP-2a, JIP-2b and JIP3, have been identified in brain.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our JNK/JIP3 Antibody and receive a gift card or discount.